Abraham Ceesay - Chief Executive Officer, Director at Rapport Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Executive Officer, Director
Issuer ticker
RAPP on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Abraham Ceesay in Rapport Therapeutics, Inc.

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-149,640
Avg price
$28.37
Total value
-$4,245,821

Net

Past year
Shares
-149,640
Share %
-100%
Total value
-$4,245,821

Reported holdings for Abraham Ceesay in Rapport Therapeutics, Inc.

Form 4 holding Chief Executive Officer, Director

Rapport Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
428,000
Estimated value
Report date
02 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Abraham Ceesay in Rapport Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .